InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-0.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Clyburn Frank, Directeur Commercial. Insider active across 4 companies, notably Merck & Co., Inc.. Aggregated, 12 filings have been recorded. Activity tracked since 4 May 2021. The latest transaction was disclosed on 1 November 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
1,191 sharesCommon StockSEC:0001610717-26-000285:0
789 sharesCommon StockSEC:0001140859-25-000053:0
368 shares@ US$234.27100.0% of flowCommon StockSEC:0001140859-24-000140:0
6,932 shares0Common StockSEC:0001610717-24-000416:0
1,324 shares0Common StockSEC:0001225208-24-003735:0
1,323 shares0Common StockSEC:0001225208-23-003149:0
2,358 shares@ US$88.050.0001% mcap37.3% of flowCommon StockSEC:0001127602-21-028169:0
2,358 shares@ US$88.0537.3% of flowCommon StockSEC:0001127602-21-028169
19,324 shares0Common StockSEC:0001127602-21-016201
19,324 shares0Common StockSEC:0001127602-21-016201:0
1,906 sharesCommon StockSEC:0001127602-21-015744
1,906 shares@ US$75.980.0000% mcap25.3% of flowCommon StockSEC:0001127602-21-015744:0
12 of 12 declarations
About Clyburn Frank
Clyburn Frank is the Executive Vice President and Chief Commercial Officer at Merck & Co., Inc. He is responsible for commercial strategy and operations, aiming to strengthen the company's position in the pharmaceutical market.
